Alopexx, Inc

/Alopexx, Inc

IPO

Alopexx, Inc

Biotechnology

We are a clinical stage biotechnology company developing novel immune therapeutics for the prevention, treatment and mitigation of bacterial, fungal, and parasitic infections that express the antigenic target poly N-acetyl glucosamine (PNAG).

Symbol

ALPX

Price Range
$5.00 - $5.00

Final Shares
3,000,000

Anticipated Date
October 5, 2022

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is orderable

To view the prospectus for Alopexx, Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange